Long-Term Outcomes in Patients with Neovascular Age-Related Macular Degeneration Who Maintain Dry Macula after Three Monthly Ranibizumab Injections
Author:
Affiliation:
1. Department of Ophthalmology, Kim’s Eye Hospital, Konyang University College of Medicine, Seoul, South Korea
2. Department of Ophthalmology, Konyang University College of Medicine, Daejeon, South Korea
Funder
Kim’s Eye Hospital Research Center, Seoul, South Korea
Publisher
Informa UK Limited
Subject
Ophthalmology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/08820538.2016.1247179
Reference20 articles.
1. Ranibizumab for Neovascular Age-Related Macular Degeneration
2. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
3. Review of Ranibizumab Trials for Neovascular Age-Related Macular Degeneration
4. An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic effect of subretinal injection of alteplase plus Conbercept for acute submacular hemorrhage secondary to polypoid choroidal vasculopathy;2023-06-05
2. Outcomes of Eyes Lost to Follow-up with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Anti-Vascular Endothelial Growth Factor;Ophthalmology Retina;2020-02
3. Early Recurrent Hemorrhage in Submacular Hemorrhage Secondary to Type 3 Neovascularization or Retinal Angiomatous Proliferation: Incidence and Influence on Visual Prognosis;Seminars in Ophthalmology;2018-08-18
4. Development of Submacular Hemorrhage in Neovascular Age-related Macular Degeneration: Influence on Visual Prognosis in a Clinical Setting;Korean Journal of Ophthalmology;2018
5. Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy;Japanese Journal of Ophthalmology;2017-11-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3